null

SARS-CoV-2 3CLpro Rabbit Polyclonal Antibody (CAB20198)

(No reviews yet) Write a Review
SKU:
CAB20198
Product Type:
Antibody
Antibody Type:
Polyclonal Antibody
Reactivity:
SARS-CoV-2
Host Species:
Rabbit
€96 - €370
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

SARS-CoV-2 3CLpro Antibody (CAB20198)

The SARS-CoV-2 3CLpro Antibody (CAB20198) is a high-quality antibody developed for reliable detection and analysis of target proteins. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. RRID Gene ID 43740578 Swiss Prot Synonym

This antibody is validated for use in WB, IF/ICC, ELISA applications and has demonstrated reactivity against SARS-CoV-2 samples.

0 Reviews

View AllClose